KAE FERBER: Open Payments
NPI 1255384749 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 56 payments from 19 companies in 2025. Trend: 2023 $2,579 · 2024 $2,817 · 2025 $1,222
Food & beverage: $1,222
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $259 |
| Novartis Pharmaceuticals Corporation | 9 | $170 |
| Novo Nordisk Inc | 3 | $164 |
| Exact Sciences Corporation | 4 | $86 |
| Lilly USA, LLC | 4 | $86 |
| Esperion Therapeutics, Inc. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Inspire Medical Systems, Inc. | 1 | $44 |
| PFIZER INC. | 2 | $41 |
| Eisai Inc. | 1 | $35 |
Products named: LEQVIO, Wegovy, OTEZLA, EVENITY, KISUNLA, NEXLETOL, The Cologuard Plus Collection Kit, FARXIGA.
Industry payments across FL — which companies pay providers there.
